WM Technology, the company behind the cannabis marketplace Weedmaps, delivered a first quarter that captures the cannabis industry's broader story in miniature: modestly profitable, disciplined on costs, but pressured on the top line by a retail environment that keeps getting tougher. The WM Technology Q1 2026 earnings show a business that has learned to operate in the black even as the dispensaries it serves cut back on advertising spend. For investors tracking cannabis tech, the report is a study in resilience over growth.
The company reported revenue of $43.6 million for the quarter ended March 31, 2026, down from $44.6 million in the prior-year period. Net income came in at $1.7 million, and adjusted EBITDA reached $5.9 million — extending a streak of consecutive quarters of adjusted EBITDA profitability. The results arrived alongside one of the more consequential structural moves in the company's history: its exit from the Nasdaq.
Advertisement
The Headline Numbers
The quarter's defining tension is between profitability and contraction. On the bottom line, WM Technology stayed firmly profitable, posting $1.7 million in net income and $5.9 million in adjusted EBITDA. That is the payoff from several years of cost discipline at a company that, like many cannabis-adjacent businesses, once prioritized growth at the expense of margins.
On the top line, though, revenue slipped to $43.6 million from $44.6 million a year earlier — a decline of roughly 2%. Management attributed the softness to continued weakness across core markets, where challenging operating conditions for cannabis operators weighed on the advertising budgets that fund Weedmaps. When dispensaries struggle, the marketing dollars they send to platforms like Weedmaps are among the first expenses to get trimmed.
The combination — shrinking revenue, sustained profitability — is the signature of a company managing decline rather than chasing expansion. It is a posture that can preserve cash and reassure creditors, but it also signals that the easy growth in cannabis tech advertising is behind it, at least for now.
Client Churn Tells the Real Story
The most revealing figures sit beneath the revenue line, in the client metrics. Average monthly paying clients fell to 4,983 from 5,179 in the prior-year period — a loss of nearly 200 paying customers. The company pinned the decline on churn in more established markets, partially offset by new client acquisitions in certain developing markets.
The cannabis market moves weekly.
Price crashes, new brands, and policy shifts — all in one email.
That geographic split is important. In mature states, where cannabis markets are saturated and price competition is brutal, dispensaries are closing or cutting marketing, and Weedmaps loses accounts. In newer markets just coming online, the platform is still adding clients. The net effect is erosion, but it is uneven — a reminder that "the cannabis market" is really dozens of distinct state markets at very different stages.
There was a silver lining in the per-client economics. Average monthly revenue per paying client actually rose, to $2,914 from $2,871 a year earlier. The company explained this as a positive mix impact: the clients churning out tended to be smaller spenders with below-average budgets, so their departure nudged the average spend of the remaining base upward. In other words, WM Technology is losing its least valuable customers while retaining the bigger advertisers — a healthier mix, even if the headcount is shrinking.
The Nasdaq Exit
The earnings landed against the backdrop of WM Technology's departure from the Nasdaq. A move off a major U.S. exchange is significant for any company, and for a cannabis-sector business it carries particular weight. Exchange listings shape which institutional investors can hold a stock, how much analyst coverage it receives, and how visible it is to the broader market.
For cannabis and cannabis-adjacent companies, the listing question has long been fraught. Federal illegality has historically limited where plant-touching businesses can list, and even ancillary technology companies like WM Technology — which does not touch the plant directly — have navigated a complicated relationship with U.S. exchanges. The Nasdaq exit reflects those pressures, and it changes the calculus for shareholders who valued the liquidity and credibility that a major-exchange listing confers.
Advertisement
How the stock, which trades under the ticker MAPS, performs in its new environment will be a test of whether profitability alone can sustain investor interest absent the visibility of a top-tier exchange.
What It Signals About Cannabis Tech
WM Technology's quarter is a useful proxy for the health of the cannabis advertising and technology layer that sits above the dispensaries. When that layer's revenue declines because operators are pulling back on marketing, it is a downstream symptom of the price compression and basket-shrinkage squeezing retailers across mature markets. Advertising is discretionary; it gets cut when margins are thin.
The flip side is that WM Technology's continued profitability shows the ancillary cannabis-tech model can work even in a downturn. Unlike plant-touching operators saddled until recently with 280E tax burdens, ancillary companies have more conventional cost structures and more flexibility to right-size. WM Technology has used that flexibility to stay profitable through a revenue decline — a discipline many plant-touching operators are still trying to achieve.
The wildcard is federal policy. The recent shift of state-licensed medical marijuana to Schedule III is expected to relieve the tax pressure on dispensaries, and if that translates into healthier operators with more to spend, advertising platforms like Weedmaps could see budgets loosen. A rebound in dispensary profitability would flow upward to the tech layer. But that is a forward bet, and this quarter reflects the environment as it stands: lean, cautious, and still contracting at the top line.
What to Watch Next
Three things will determine whether WM Technology's narrative shifts from managed decline to renewed growth. First, whether client churn in mature markets stabilizes or accelerates — the paying-client count is the cleanest read on demand. Second, whether revenue per client keeps climbing, which would suggest the company is successfully concentrating on higher-value advertisers. And third, whether the broader dispensary recovery that rescheduling is supposed to enable actually materializes and lifts marketing budgets.
It is also worth watching how WM Technology invests whatever cash its profitability generates. A company managing decline can simply harvest margins and shrink, or it can use its stability to build new products, deepen its data and analytics offerings, or expand into developing markets before competitors arrive. The choice between those paths will say a lot about whether management sees the current softness as a temporary trough or a permanent ceiling. Weedmaps remains one of the most recognized brands in cannabis, and brand strength is an asset that can be monetized in more ways than display advertising alone.
For now, WM Technology has done the hard part of staying profitable through a difficult stretch. The harder part — returning to growth — depends on a cannabis retail recovery that has been promised before and has yet to fully arrive.
Key Takeaways
- WM Technology reported Q1 2026 revenue of $43.6 million, down from $44.6 million a year earlier, with $1.7 million net income and $5.9 million adjusted EBITDA.
- Average monthly paying clients fell to 4,983 from 5,179, driven by churn in mature markets and partly offset by new clients in developing markets.
- Revenue per paying client rose to $2,914 from $2,871, as smaller, below-average spenders churned out.
- The company exited the Nasdaq, a structurally significant move for the MAPS stock and its investor base.
- Continued profitability through a revenue decline shows the ancillary cannabis-tech model's resilience; a rebound hinges on a broader dispensary recovery.
This article is for informational purposes only and is not financial advice. Budpedia is not a financial advisor; consider consulting a licensed professional before making investment decisions.
Explore cannabis news, find dispensaries, and join the community at Budpedia.
Liked this? There's more every Friday.
The Budpedia Weekly: cannabis laws, science, deals, and strain reviews in your inbox.